Chinese expert consensus on the management of hypertension in adults with type 2 diabetes

被引：1

作者：

Pan, Xiaohui ^{[1
]}

He, Hongbo ^{[2
,3
]}

Bao, Yuqian ^{[4
]}

Bi, Yan ^{[5
]}

Chen, Luyuan ^{[6
,7
]}

Chen, Xiaoping ^{[8
]}

Fang, Hui ^{[9
]}

Feng, Wenhuan ^{[5
]}

Gao, Ling ^{[10
]}

Guo, Lixin ^{[11
,12
,13
]}

Guo, Yifang ^{[14
]}

Han, Yaling ^{[15
,16
]}

Hua, Qi ^{[17
]}

Li, Nanfang ^{[18
]}

Li, Quanmin ^{[19
]}

Li, Yan ^{[20
,21
]}

Li, Yong ^{[22
]}

Li, Xialian ^{[23
]}

Liu, Jing ^{[24
]}

Ma, Huijuan ^{[25
]}

Mu, Jianjun ^{[26
]}

Nong, Kailei ^{[1
]}

Shang, Huiqian ^{[27
]}

Shen, Yunfeng ^{[28
]}

Shi, Zhongwei ^{[29
]}

Sun, Fang ^{[30
]}

Sun, Ningling ^{[24
]}

Tao, Jun ^{[31
]}

Wang, Jiguang ^{[21
,32
]}

Wang, Xinling ^{[33
]}

Wu, Jing ^{[34
]}

Xiao, Xinhua ^{[35
]}

Xie, Liangdi ^{[36
]}

Xu, Jing ^{[37
,38
]}

Ye, Hongying ^{[39
]}

Yu, Dongni ^{[11
]}

Yuan, Hong ^{[40
]}

Zhang, Huijie ^{[41
]}

Zhang, Jian ^{[42
]}

Zhang, Lili ^{[43
]}

Zhang, Yuqing ^{[44
]}

Zhou, Jiaqiang ^{[45
]}

Zhou, Xinli ^{[46
]}

Zhu, Dalong ^{[5
]}

Zhu, Tiehong ^{[46
]}

Li, Sheyu ^{[1
]}

Zhu, Zhiming ^{[2
,3
]}

机构：

[1] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China

[2] Army Med Univ, Chongqing Inst Hypertens, Chongqing, Peoples R China

[3] Chongqing Inst Hypertens, Chongqing, Peoples R China

[4] Shanghai Jiao Tong Univ, Dept Otorhinolaryngol, Peoples Hosp 6, Sch Med, Shanghai, Peoples R China

[5] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Endocrinol, Nanjing, Peoples R China

[6] Peoples Hosp Guangdong Prov, Dept Cardiol, Guangzhou, Peoples R China

[7] Guangzhou Inst Cardiovasc Dis, Guangzhou, Peoples R China

[8] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China

[9] Hebei Med Univ, Tangshan City Workers Hosp, Dept Endocrinol, Tangshan 063000, Hebei, Peoples R China

[10] Wuhan Univ, Dept Endocrinol, Renmin Hosp, Wuhan, Peoples R China

[11] Beijing Hosp, Minist Hlth, Dept Endocrinol, Beijing, Peoples R China

[12] China Natl Ctr Bioinformat, Beijing, Peoples R China

[13] Chinese Acad Med Sci, Inst Geriatr, Beijing, Peoples R China

[14] Hebei Gen Hosp, Dept Geriatr Cardiovasc Med, Shijiazhuang, Peoples R China

[15] Gen Hosp Northern Theater Command, Dept Cardiol, Shenyang, Peoples R China

[16] Shenyang Mil Command, Shenyang, Peoples R China

[17] Capital Med Univ, Xuanwu Hosp, Dept Cardiol, Beijing, Peoples R China

[18] Peoples Hosp Xinjiang Uygur Autonomous Reg, Ctr Hypertens, Urumqi, Peoples R China

[19] PLA Rocket Force Characterist Med Ctr, Dept Endocrinol, Beijing, Peoples R China

[20] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai, Peoples R China

[21] Shanghai Res Inst Hypertens, Shanghai, Peoples R China

[22] Fudan Univ, Huashan Hosp, Dept Cardiol, Shanghai, Peoples R China

[23] Zhengzhou Univ, Affiliated Hosp 1, Dept Endocrinol, Zhengzhou, Peoples R China

[24] Peking Univ Peoples Hosp, Cardiovasc Med Dept, Beijing, Peoples R China

[25] Hebei Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shijiazhuang, Hebei, Peoples R China

[26] Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Xian, Peoples R China

[27] Zunyi Med Univ, Dept Cardiovasc Med, Affiliated Hosp, Zunyi, Peoples R China

[28] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Endocrinol & Metab, Shenzhen, Peoples R China

[29] Army Med Univ, Daping Hosp, Army Special Med Ctr, Dept Hypertens & Endocrinol, Chongqing, Peoples R China

[30] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China

[31] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai, Peoples R China

[32] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Endocrinol, Urumqi, Peoples R China

[33] Cent South Univ, Dept Endocrinol, Xiangya Hosp, Changsha, Peoples R China

[34] Univ South China, Affiliated Hosp 1, Dept Endocrinol & Metab, Changsha, Peoples R China

[35] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China

[36] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Endocrinol, Xian, Peoples R China

[37] Army Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China

[38] Fudan Univ, Huashan Hosp, Dept Endocrinol, Shanghai, Peoples R China

[39] Cent South Univ, Dept Gynecol, Xiangya Hosp 3, Changsha, Peoples R China

[40] Southern Med Univ, Nanfang Hosp, Dept Endocrinol, Guangzhou, Peoples R China

[41] Hubei Prov Hosp TCM, Dept Encephalopathy, Wuhan, Peoples R China

[42] Chongqing Med Univ, Dept Cardiol, Affiliated Hosp 2, Chongqing, Peoples R China

[43] Chinese Acad Med Sci, Dept Cardiovasc Surg, Fuwai Hosp, Beijing, Peoples R China

[44] Zhejiang Univ, Sir Run Shaw Hosp, Sch Med, Dept Endocrinol & Metab, Hangzhou, Peoples R China

[45] Shandong First Med Univ, Dept Endocrinol & Metab, Shandong Prov Hosp, Jinan, Peoples R China

[46] Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin, Peoples R China

来源：

JOURNAL OF EVIDENCE BASED MEDICINE | 2024年 / 17卷 / 04期

基金：

中国国家自然科学基金;

关键词：

anti-hypertensive treatment; blood pressure monitor; hypertension; screening for hypertension; type; 2; diabetes; ALL-CAUSE MORTALITY; BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; DISEASE; EFFICACY; SODIUM; HOME; MELLITUS; DYSFUNCTION; INHIBITORS;

D O I：

10.1111/jebm.12655

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Both hypertension and type 2 diabetes are attributable to premature death, cardiovascular and kidney diseases with largely overlapping population. Followed the GRADE approach, this expert consensus aimed to reduce the cardiovascular and kidney death and disability due to hypertension and minimize the treatment burden in adults with type 2 diabetes. Through online survey and discussion, a multidisciplinary team comprehensively prioritized seven key guideline questions. Informed by the evidence synthesis and online discussion, the team developed 12 recommendations under the GRADE Evidence-to-decision (EtD) framework. The recommendations covered the screening of hypertension in adults diagnosed with type 2 diabetes but not hypertension and the monitoring, lifestyle interventions, and medications in those diagnosed with type 2 diabetes and hypertension.

引用

页码：851 / 864

页数：14

共 50 条

[21] Management of fracture risk in patients with diabetes-Chinese Expert Consensus
Liu, Jian-Min
Zhu, Da-Long
Mu, Yi-Ming
Xia, Wei-Bo
JOURNAL OF DIABETES, 2019, 11 (11) : 906 - 919
[22] Plasma Proteomics of Type 2 Diabetes, Hypertension, and Co-Existing Diabetes/Hypertension in Thai Adults
Fakfum, Puriwat
Chuljerm, Hataichanok
Parklak, Wason
Roytrakul, Sittiruk
Phaonakrop, Narumon
Lerttrakarnnon, Peerasak
Kulprachakarn, Kanokwan
LIFE-BASEL, 2024, 14 (10):
[23] Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus
Seidu, Samuel
Avery, Lorraine
Bell, Heather
Brown, Pam
Diggle, Jane
Down, Su
Dua, Ritesh
Holmes, Patrick
Mohan, Rahul
Milne, Nicola
Min, Thinzar
Ridgeway, James
Tahir, Waqas
Tanna, Sanjay
DIABETIC MEDICINE, 2025, 42 (03)
[24] Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults
Yu, Danxia
Moore, Steven C.
Matthews, Charles E.
Xiang, Yong-Bing
Zhang, Xianglan
Gao, Yu-Tang
Zheng, Wei
Shu, Xiao-Ou
METABOLOMICS, 2016, 12 (01) : 1 - 11
[25] Cognitive and gait decrements among non-demented older adults with Type 2 diabetes or hypertension: a systematic review
Niermeyer, Madison A.
CLINICAL NEUROPSYCHOLOGIST, 2018, 32 (07) : 1256 - 1281
[26] Hypertension in patients with type 2 diabetes mellitus: Targets and management
Pavlou, Dimitra, I
Paschou, Stavroula A.
Anagnostis, Panagiotis
Spartalis, Michael
Spartalis, Eleftherios
Vryonidou, Andromachi
Tentolouris, Nicholas
Siasos, Gerasimos
MATURITAS, 2018, 112 : 71 - 77
[27] Expert consensus on the management of hypertension in the young and middle-aged Chinese population
Liu, Jing
Lu, Xinzheng
Chen, Luyuan
Huo, Yong
Bu, Peili
Cai, Jun
Chen, Xiaoping
Feng, Yingqing
Gao, Pingjin
Guo, Zihong
Hao, Yuming
He, Yubin
Hua, Qi
Huang, Jing
Jiang, Yinong
Lei, Han
Li, Nanfang
Lin, Jinxiu
Liu, Wei
Lu, Xiang
Mu, Jianjun
Shang, Qianhui
Shi, Dongmei
Sun, Gang
Sun, Ningling
Sun, Yingxian
Sun, Yuemin
Tao, Jun
Wang, Jiguang
Wang, Xiaozeng
Xie, Liangdi
Xu, Xinjuan
Yao, Zhuhua
Yu, Jing
Yuan, Hong
Zhang, Liangqing
Zhang, Xinhua
Zhao, Luosha
Zhao, Xin
Zhao, Xingsheng
Zhao, Yafeng
Zhu, Zhiming
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (12)
[28] Independent and interactive effect of type 2 diabetes and hypertension on memory functions in middle aged adults
Kalcza Janosi, Kinga
Lukacs, Andrea
BMC ENDOCRINE DISORDERS, 2023, 23 (01)
[29] Blood Pressure Management in Patients with Type 2 Diabetes
Eguchi, Kazuo
INTERNAL MEDICINE, 2015, 54 (18) : 2285 - 2289
[30] Blood pressure and cardiovascular diseases in Chinese adults with type 2 diabetes: A prospective cohort study
Bragg, Fiona
Halsey, Jim
Guo, Yu
Zhang, Hua
Yang, Ling
Sun, Xiaohui
Pei, Pei
Chen, Yiping
Du, Huaidong
Yu, Canqing
Clarke, Robert
Lv, Jun
Chen, Junshi
Li, Liming
Chen, Zhengming
LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2021, 7

← 1 2 3 4 5 →